BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. SPY
4. IQMX
5. EROC
6. MSTR
7. NVDA
8. RIVN
9. TSLA
10. MSFT

Go back to BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
(NASDAQ: BBIO) Delayed: 77.75 +0.56 (0.73%)
Previous Close $77.19    52 Week High $ 
Open $77.48    52 Week Low $ 
Day High $79.25    P/E N/A 
Day Low $77.15    EPS $ 
Volume 3,137,228